Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive
Copyright © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved..
Cardiovascular conditions are among the most frequent causes of impairment to drive, because they might induce unpredictable mental state alterations via diverse mechanisms like myocardial ischemia, cardiac arrhythmias, and vascular dysfunction. Accordingly, health professionals are often asked to assess patients' fitness to drive (FTD). The Canadian Cardiovascular Society previously published FTD guidelines in 2003-2004; herein, we present updated FTD guidelines. Because there are no randomized trials on FTD, observational studies were used to estimate the risk of driving impairment in each situation, and recommendations made on the basis of Canadian Cardiovascular Society Risk of Harm formula. More restrictive recommendations were made for commercial drivers, who spend longer average times behind the wheel, use larger vehicles, and might transport a larger number of passengers. We provide guidance for individuals with: (1) active coronary artery disease; (2) various forms of valvular heart disease; (3) heart failure, heart transplant, and left ventricular assist device situations; (4) arrhythmia syndromes; (5) implantable devices; (6) syncope history; and (7) congenital heart disease. We suggest appropriate waiting times after cardiac interventions or acute illnesses before driving resumption. When short-term driving cessation is recommended, recommendations are on the basis of expert consensus rather than the Risk of Harm formula because risk elevation is expected to be transient. These recommendations, although not a substitute for clinical judgement or governmental regulations, provide specialists, primary care providers, and allied health professionals with a comprehensive list of a wide range of cardiac conditions, with guidance provided on the basis of the level of risk of impairment, along with recommendations about ability to drive and the suggested duration of restrictions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
The Canadian journal of cardiology - 40(2024), 4 vom: 26. Apr., Seite 500-523 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Co-chairs: [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 26.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cjca.2023.09.033 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363139206 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363139206 | ||
| 003 | DE-627 | ||
| 005 | 20240427232001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cjca.2023.09.033 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1390.xml |
| 035 | |a (DE-627)NLM363139206 | ||
| 035 | |a (NLM)37820870 | ||
| 035 | |a (PII)S0828-282X(23)01755-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Co-chairs: |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 26.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Cardiovascular conditions are among the most frequent causes of impairment to drive, because they might induce unpredictable mental state alterations via diverse mechanisms like myocardial ischemia, cardiac arrhythmias, and vascular dysfunction. Accordingly, health professionals are often asked to assess patients' fitness to drive (FTD). The Canadian Cardiovascular Society previously published FTD guidelines in 2003-2004; herein, we present updated FTD guidelines. Because there are no randomized trials on FTD, observational studies were used to estimate the risk of driving impairment in each situation, and recommendations made on the basis of Canadian Cardiovascular Society Risk of Harm formula. More restrictive recommendations were made for commercial drivers, who spend longer average times behind the wheel, use larger vehicles, and might transport a larger number of passengers. We provide guidance for individuals with: (1) active coronary artery disease; (2) various forms of valvular heart disease; (3) heart failure, heart transplant, and left ventricular assist device situations; (4) arrhythmia syndromes; (5) implantable devices; (6) syncope history; and (7) congenital heart disease. We suggest appropriate waiting times after cardiac interventions or acute illnesses before driving resumption. When short-term driving cessation is recommended, recommendations are on the basis of expert consensus rather than the Risk of Harm formula because risk elevation is expected to be transient. These recommendations, although not a substitute for clinical judgement or governmental regulations, provide specialists, primary care providers, and allied health professionals with a comprehensive list of a wide range of cardiac conditions, with guidance provided on the basis of the level of risk of impairment, along with recommendations about ability to drive and the suggested duration of restrictions | ||
| 650 | 4 | |a Guideline | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Guerra, Peter G |e verfasserin |4 aut | |
| 700 | 1 | |a Simpson, Christopher S |e verfasserin |4 aut | |
| 700 | 1 | |a Van Spall, Harriette G C |e verfasserin |4 aut | |
| 700 | 0 | |a Writing Panel: |e verfasserin |4 aut | |
| 700 | 1 | |a Asgar, Anita W |e verfasserin |4 aut | |
| 700 | 1 | |a Billia, Phyllis |e verfasserin |4 aut | |
| 700 | 1 | |a Cadrin-Tourigny, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Chakrabarti, Santabhanu |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Christopher C |e verfasserin |4 aut | |
| 700 | 1 | |a Dore, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Fordyce, Christopher B |e verfasserin |4 aut | |
| 700 | 1 | |a Gouda, Pishoy |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Ansar |e verfasserin |4 aut | |
| 700 | 1 | |a Krahn, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Luc, Jessica G Y |e verfasserin |4 aut | |
| 700 | 1 | |a Mak, Susanna |e verfasserin |4 aut | |
| 700 | 1 | |a McMurtry, Sean |e verfasserin |4 aut | |
| 700 | 1 | |a Norris, Colleen |e verfasserin |4 aut | |
| 700 | 1 | |a Philippon, Francois |e verfasserin |4 aut | |
| 700 | 1 | |a Sapp, John |e verfasserin |4 aut | |
| 700 | 1 | |a Sheldon, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Silversides, Candice |e verfasserin |4 aut | |
| 700 | 1 | |a Steinberg, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, David A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Canadian journal of cardiology |d 1993 |g 40(2024), 4 vom: 26. Apr., Seite 500-523 |w (DE-627)NLM012635553 |x 1916-7075 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2024 |g number:4 |g day:26 |g month:04 |g pages:500-523 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cjca.2023.09.033 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2024 |e 4 |b 26 |c 04 |h 500-523 | ||